Aurobindo sells Natrol to New Mountain Capital

New Mountain Capital has reached a definitive agreement with Aurobindo Pharma to acquire Natrol and combine it with Jarrow Formulas, another New Mountain Capital portfolio company. 

Headquartered in Los Angeles, Calif., Natrol is a leading vitamins, minerals and supplements brand focused on vital human health areas including sleep, mood & stress, brain health, beauty and immunity.

“Aurobindo is committed to evaluating and concluding strategic options towards focused portfolio enhancement with the ultimate objective of enhancing stakeholder values. We are pleased to enter into an agreement to sell the Natrol business to an outstanding private equity player, who can focus additional resources to grow Natrol, its products and brands further. On behalf of the Aurobindo Group, my heartful thanks to all stakeholders including employees, who have supported in acquiring and bringing Natrol to a growth path in the past 6 years,” said N. Govindarajan, managing director, Aurobindo. 

Govindarajan added, “Proceeds from Natrol’s divestiture will be used to reduce debt and other new strategic initiatives.”

“Throughout its history, Natrol has stood for the highest quality products designed to drive positive outcomes and enhance quality of life for its users,” said Andre Moura, managing director at New Mountain Capital. “We thank Aurobindo for their stewardship of Natrol over the last six years, and we look forward to working closely with the management teams at Natrol and Jarrow Formulas to build upon Natrol’s strong momentum and drive continued growth and market-leading innovation.”

The transaction is expected to close by January 2021 subject to customary closing conditions and regulatory approvals.

“Simpson Thacher & Bartlett acted as legal counsel to New Mountain Capital. Jefferies served as the sole financial advisor to Aurobindo, and Sullivan & Cromwell acted as legal counsel to Aurobindo.